Cinclus Pharma Holding AB (publ) (STO:CINPHA)
Sweden flag Sweden · Delayed Price · Currency is SEK
12.62
+0.20 (1.61%)
At close: Sep 4, 2026

Cinclus Pharma Holding AB Ratios and Metrics

Millions SEK. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
587896995---
Market Cap Growth
-18.37%-9.92%----
Enterprise Value
254365351---
Last Close Price
12.6219.2621.38---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
16.7015.60217.24---
PB Ratio
2.902.431.79---
P/TBV Ratio
2.902.431.79---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
7.226.3576.67---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.270.020.00-1.710.000.01
Net Debt / Equity Ratio
-1.64-1.30-1.02-0.56-1.36-1.08
Net Debt / EBITDA Ratio
1.152.423.35-0.210.821.62
Net Debt / FCF Ratio
1.196.333.18-0.210.901.81
Asset Turnover
0.070.100.010.040.06-
Quick Ratio
2.173.7212.620.563.997.17
Current Ratio
2.303.9313.200.574.017.47
Return on Equity (ROE)
-79.92%-39.79%-70.23%-859.20%-196.14%-45.79%
Return on Assets (ROA)
-34.71%-21.59%-30.36%-89.35%-79.11%-29.29%
Return on Capital Employed (ROCE)
-119.30%-48.40%-30.40%286.10%-150.90%-66.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-45.87%-20.52%-16.89%---
FCF Yield
-47.64%-8.46%-17.93%---
Buyback Yield / Dilution
-22.55%-25.69%-41.26%-13.81%-9.26%-8415.70%